Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer.
Oncogene
; 34(16): 2094-102, 2015 Apr 16.
Article
in En
| MEDLINE
| ID: mdl-24931166
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Biomarkers, Tumor
/
RNA, Antisense
/
TRPM Cation Channels
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
Oncogene
Journal subject:
BIOLOGIA MOLECULAR
/
NEOPLASIAS
Year:
2015
Type:
Article
Affiliation country:
Italy